Results 271 to 280 of about 15,788 (287)

Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis

Nature Genetics, 2006
Alan D Irvine, Somnath Mukhopadhyay, W H Irwin Mclean   +2 more
exaly  

Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Lancet, The, 2020
Rd Sinclair, Andreas Wollenberg, Michael J Cork   +2 more
exaly  

Mechanisms in irritant contact dermatitis

Clinics in Dermatology, 1997
openaire   +3 more sources

Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis

Nature Genetics, 2015
Lavinia Paternoster, Marie Standl, Johannes Waage   +2 more
exaly  

The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis

Nature Immunology, 2018
Teruki Dainichi, Atsushi Otsuka, Saeko Nakajima   +2 more
exaly  

Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

Lancet, The, 2017
Andrew Blauvelt, Marjolein de Bruin-Weller, Melinda Gooderham   +2 more
exaly  

Genome-wide association study identifies eight new susceptibility loci for atopic dermatitis in the Japanese population

Nature Genetics, 2012
Atsushi Takahashi, Tatushiko Tsunoda, Nobuhiro Nakano   +2 more
exaly  

Meta-analysis of genome-wide association studies identifies three new risk loci for atopic dermatitis

Nature Genetics, 2011
Lavinia Paternoster, Marie Standl, Adaikalavan Ramasamy   +2 more
exaly  

Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial

Lancet, The, 2016
Lisa A Beck, Thomas Bieber, Andrew Blauvelt   +2 more
exaly  

Mast cell–derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B

Nature Immunology, 2007
Mindy Tsai, Stephen J Galli
exaly